National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
West China Hospital Emergency Department, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Adv Sci (Weinh). 2023 Oct;10(28):e2301478. doi: 10.1002/advs.202301478. Epub 2023 Aug 17.
The receptor-binding domain (RBD) of spike recognizing the receptor angiotensin-converting enzyme 2 (ACE2) initiates membrane fusion between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cell membrane. Although the structure of the RBD_ACE2 complex has been well studied, its functional mechanism in membrane fusion is still not fully understood. Here, using an in vitro cell-vesicle content-mixing assay, it is found that the cleavage at the S2' site by thrombin (Thr) protease strongly accelerates membrane fusion, compared to that of cleavage at the S1/S2 site by PreScission (3C) protease. Moreover, mutations at the RBD_ACE2 interface resulted in a positive correlation between binding affinity and fusion probability. In both the cell-vesicle and cell-cell fusion assays, by crosslinking two membranes via the neutravidin (NTV)_biotin interaction or complementary DNA strands, it is found that spike drives membrane fusion in the absence of ACE2, and a suitable distance between two membranes is critical for spike-mediated membrane fusion. Finally, unsuitable membrane crosslinkers significantly inhibited the fusion probability in the presence of ACE2. Taken together, the results suggest that the RBD_ACE2 complex may act as a crosslinker to bridge the viral and cell membranes at a suitable distance, which is critical, but also substitutable for spike-mediated SARS-CoV-2 entry.
刺突蛋白的受体结合域(RBD)识别血管紧张素转换酶 2(ACE2)受体,启动严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与细胞膜之间的膜融合。尽管 RBD_ACE2 复合物的结构已经得到了很好的研究,但它在膜融合中的功能机制仍不完全清楚。在这里,通过体外细胞-囊泡内容物混合测定,发现凝血酶(Thr)蛋白酶在 S2' 位点的切割比 PreScission(3C)蛋白酶在 S1/S2 位点的切割强烈加速膜融合。此外,RBD_ACE2 界面的突变导致结合亲和力和融合概率之间呈正相关。在细胞-囊泡和细胞-细胞融合测定中,通过通过链霉亲和素(NTV)-生物素相互作用或互补 DNA 链交联两个膜,发现刺突蛋白在没有 ACE2 的情况下驱动膜融合,并且两个膜之间的合适距离对于刺突介导的膜融合至关重要。最后,不合适的膜交联剂在存在 ACE2 的情况下显著抑制融合概率。总之,结果表明 RBD_ACE2 复合物可能充当交联剂,在合适的距离桥接病毒和细胞膜,这是至关重要的,但也可替代刺突介导的 SARS-CoV-2 进入。